Exposure to a chemical called PFDA may be linked to breast cancer risk in a non-linear way: at very low levels, risk appears lower than average, but above a concentration of about 1.3 micrograms per...
Mechanism
Synthesis from 1 study
At low levels, the body can still handle this chemical and keep breast tissue healthy. But when levels get too high, it blocks the body’s ability to clean out harmful hormones, stops cells from communicating, and causes DNA damage that lets abnormal cells survive and grow — leading to higher cancer...
Most probable mechanism
At low levels, the body can still manage the chemical by breaking it down and keeping cells communicating properly, which keeps tissue healthy. But when the chemical builds up beyond a certain point, it blocks the body’s ability to remove harmful substances like excess estrogen, stops cells from talking to each other, and causes DNA damage through oxidative stress. This lets damaged cells survive and multiply, increasing the chance of cancer starting in breast tissue.
PFDA enters epithelial cells in breast and ovarian tissues through passive diffusion or membrane transporters
PFDA inhibits UDP-glucuronosyltransferase enzymes, reducing the conjugation and elimination of endogenous estrogens and environmental carcinogens
Accumulation of unconjugated estrogens increases local estrogen exposure in breast tissue, promoting estrogen receptor signaling and DNA replication stress
PFDA disrupts gap junctional intercellular communication by altering connexin protein function and calcium homeostasis, impairing coordinated cell cycle control
PFDA induces mitochondrial dysfunction and NADPH oxidase activation, generating reactive oxygen species that overwhelm antioxidant defenses
Oxidative stress causes DNA lesions, genomic instability, and inhibition of DNA repair mechanisms
Impaired apoptosis and persistent survival signals allow DNA-damaged cells to evade cell death and proliferate
Chronic low-grade inflammation from NLRP3 inflammasome activation recruits immune cells and remodels the tissue microenvironment to favor tumor initiation
Less supported by current evidence, but not ruled out
At higher concentrations, the chemical interferes with the molecular tags that control gene activity, turning off protective genes and turning on harmful ones, which can lead to uncontrolled cell growth.
PFDA binds to and inhibits DNA methyltransferase enzymes
Global DNA hypomethylation and promoter-specific hypermethylation occur, silencing tumor suppressor genes and activating oncogenic pathways
Epigenetic dysregulation enhances cell proliferation, migration, and resistance to cell death
Evidence from Studies
Supporting (1)
Community contributions welcome
Perfluoroalkyl and polyfluoroalkyl substances and Cancer risk: results from a dose-response Meta-analysis
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.